Index | Before treatment (n=59) | After treatment (n=59) |
---|
Intervention group | Control group | P value | Intervention group | Control group | P value |
---|
Male/female/n | 3/56 | 4/55 | 0.726 | | | | Age/year | 46±13 | 44±15 | 0.852 | | | | Duration of HT/month | 23 (7, 31) | 26 (8, 34) | 0.607 | 29 (13, 37) | 32 (14, 40) | 0.607 | Smoke/[n(%)] | 0 (0) | 0 (0) | 1.000 | 0 (0) | 0 (0) | 1.000 | Drink/[n(%)] | 0 (0) | 0 (0) | 1.000 | 0 (0) | 0 (0) | 1.000 | BMI/(kg·m-2) | 22.4±3.5 | 23.2±3.1 | 0.624 | 22.7±3.6 | 23.5±3.4 | 0.655 | Scr/(μmol·L-1) | 61.2±15.4 | 59.1±16.1 | 0.682 | 60.4±14.8 | 60.7±17.5 | 0.832 | eGFR/(mL·min-1·1.73-1·m-2) | 117.1±24.3 | 120.4±25.1 | 0.734 | 114.7±23.5 | 117.8±23.3 | 0.855 | GPT/(U·L-1) | 24±12 | 23±10 | 0.567 | 23±11 | 24±10 | 0.786 | AST/(U·L-1) | 21 (16, 31) | 23 (14, 29) | 0.301 | 20 (12, 28) | 24 (14, 43) | 0.243 | γ-GT/(U·L-1) | 32.5 (17.5, 41.0) | 35.3 (18.1, 43.4) | 0.661 | 31.2 (15.7, 42.2) | 37.9 (19.0, 45.6) | 0.318 | TC/(mmol·L-1) | 5.12±1.34 | 4.96±1.60 | 0.620 | 4.84±1.40 | 4.91±1.28 | 0.701 | TAG/(U·L-1) | 2.56 (1.26, 4.07) | 2.69 (1.42, 3.93) | 0.734 | 2.47 (1.16, 4.22) | 2.78 (1.67, 4.33) | 0.796 | MUI/(μg·L-1) | 145 (106, 187) | 149 (110, 190) | 0.864 | 128 (95, 171) | 135 (108, 178) | 0.764 | Thyroid gland/cm3 | 25.53 (18.79, 28.35) | 24.35 (17.02, 26.23) | 0.805 | 23.47 (17.43, 26.18) | 23.05 (16.53, 25.62) | 0.909 |
|